BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 15350488)

  • 41. Improvement in disequilibrium symptoms during dialysis with low glucose dialyzate.
    Raju SF; White AR; Barnes TT; Smith PP; Kirchner KA
    Clin Nephrol; 1982 Sep; 18(3):126-9. PubMed ID: 7140023
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Minutes to recovery after a hemodialysis session: a simple health-related quality of life question that is reliable, valid, and sensitive to change.
    Lindsay RM; Heidenheim PA; Nesrallah G; Garg AX; Suri R;
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):952-9. PubMed ID: 17699312
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glucose-added dialysis fluid prevents asymptomatic hypoglycaemia in regular haemodialysis.
    Burmeister JE; Scapini A; da Rosa Miltersteiner D; da Costa MG; Campos BM
    Nephrol Dial Transplant; 2007 Apr; 22(4):1184-9. PubMed ID: 17272314
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical research on individualized hemodialysis preventing unconventional hypotension in diabetic nephropathy patient.
    Li WH; Yin YM; Chen H; Rui ZR; Yuan Y; Yun H; Wang JW
    Int J Artif Organs; 2020 Apr; 43(4):229-233. PubMed ID: 31665956
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intradialytic complications during hemodialysis.
    Davenport A
    Hemodial Int; 2006 Apr; 10(2):162-7. PubMed ID: 16623668
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hemodialysis-induced hypotension: impact of technologic advances.
    Donauer J
    Semin Dial; 2004; 17(5):333-5. PubMed ID: 15461736
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Sodium-ultrafiltration gradient method in hemodialysis].
    Nakao T; Tomonari H; Tajima N; Koga A
    Nihon Rinsho; 1991 Dec; 49 Suppl():343-7. PubMed ID: 1808280
    [No Abstract]   [Full Text] [Related]  

  • 48. Improved intradialytic stability during haemodialysis with blood volume-controlled ultrafiltration.
    Gabrielli D; Krystal B; Katzarski K; Youssef M; Hachache T; Lopot F; Lasseur C; Gunne T; Draganov B; Wojke R; Gauly A
    J Nephrol; 2009; 22(2):232-40. PubMed ID: 19384841
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Can advances in hemodialysis machine technology prevent intradialytic hypotension?
    Davenport A
    Semin Dial; 2009; 22(3):231-6. PubMed ID: 19572996
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Control of arterial hypertension by means of a regimen of hemodialysis on alternate days (HDAA or EODD: "Every Other Day Dialysis") versus 2 conventional regiments of 4 and 5 hours per session 3 times a week with 72 hours without sessions during the weekends].
    Lozano A; Benavides B; Quirós P; Jiménez-Moreno J; Figueroa E; Fernández-Marchena D; García-Pérez MA; Fernández-Ruiz E
    Nefrologia; 2006; 26(6):695-702. PubMed ID: 17227247
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Blood pressure control and symptomatic intradialytic hypotension in diabetic haemodialysis patients: a cross-sectional survey.
    Davenport A; Cox C; Thuraisingham R
    Nephron Clin Pract; 2008; 109(2):c65-71. PubMed ID: 18560240
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Temperature dialysate and hemodialysis tolerance].
    Teruel JL; Martins J; Merino JL; Fernández Lucas M; Rivera M; Marcén R; Quereda C; Ortuño J
    Nefrologia; 2006; 26(4):461-8. PubMed ID: 17058858
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Undertreatment of symptoms in patients on maintenance hemodialysis.
    Claxton RN; Blackhall L; Weisbord SD; Holley JL
    J Pain Symptom Manage; 2010 Feb; 39(2):211-8. PubMed ID: 19963337
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anxiety and complications in patients on hemodialysis.
    Parker KP
    Nurs Res; 1981; 30(6):334-6. PubMed ID: 6913879
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Midodrine (Gutron) treatment of permanent arterial hypotension in a chronic hemodialysis patient].
    Montagnac R; Clavel P; Delhotal-Landes B; Flouvat B; Poulain S; Schillinger F
    Nephrologie; 2000; 21(4):179-83. PubMed ID: 10976433
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intradialytic parenteral nutrition in hemodialysis patients: Acute and chronic intervention.
    Avery-Lynch M
    CANNT J; 2006; 16(2):30-3. PubMed ID: 16875291
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Levocarnitine Decreases Intradialytic Hypotension Episodes: A Randomized Controlled Trial.
    Ibarra-Sifuentes HR; Del Cueto-Aguilera Á; Gallegos-Arguijo DA; Castillo-Torres SA; Vera-Pineda R; Martínez-Granados RJ; Atilano-Díaz A; Cuellar-Monterrubio JE; Pezina-Cantú CO; Martínez-Guevara EJ; Ortiz-Treviño JF; Delgado-García GR; Martínez-Jiménez JG; Cruz-Valdez J; Sánchez-Martínez C
    Ther Apher Dial; 2017 Oct; 21(5):459-464. PubMed ID: 28805348
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cool dialysate reduces asymptomatic intradialytic hypotension and increases baroreflex variability.
    Chesterton LJ; Selby NM; Burton JO; McIntyre CW
    Hemodial Int; 2009 Apr; 13(2):189-96. PubMed ID: 19432693
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevention of intraocular pressure elevations during hemodialysis.
    Minguela I; Andonegui J; Aurrekoetxea B; Ruiz De Gauna R
    Am J Kidney Dis; 2000 Jul; 36(1):197-8. PubMed ID: 10873891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.